...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith trial partners
5
Jan 29, 2023 02:49PM
1
Jan 30, 2023 10:16AM

"However, the first home run for ZEN-3694 in collaboration with a BP, management may decide to sell off the epigenetic drug. What they will do with the cash is another story."

 

yep, wouldn't surprise me if a portion of cash/maybe large flowed into rvx?- don't believe this would be very fair to those who just held zen & not so sure how folks who held both would feel either? If a person just held rvx , prob good?

not sure how or IF any of the above could or will happen?

2
Jan 30, 2023 03:07PM
3
Jan 30, 2023 03:27PM
3
Jan 30, 2023 06:05PM
2
Jan 30, 2023 07:22PM
3
Jan 31, 2023 06:44AM
2
Jan 31, 2023 10:27AM
1
Feb 01, 2023 01:13PM
5
Feb 01, 2023 06:42PM
2
Feb 01, 2023 08:07PM
3
Feb 01, 2023 09:11PM
2
Feb 01, 2023 11:14PM
5
Feb 02, 2023 02:15AM
5
Feb 02, 2023 12:24PM
2
Feb 02, 2023 12:31PM
2
Feb 02, 2023 02:00PM
3
Feb 02, 2023 03:16PM
2
Feb 02, 2023 03:59PM
2
Feb 02, 2023 04:24PM
1
Feb 02, 2023 06:54PM
2
Feb 04, 2023 06:40PM
Share
New Message
Please login to post a reply